BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35504003)

  • 21. The accelerator-based boron neutron capture reaction evaluation system for head and neck cancer.
    Wang S; Igawa K; Ogawara R; Suda M; Hamano T; Ibaragi S; Hanafusa T; Ichikawa Y; Sasaki A
    Appl Radiat Isot; 2020 Nov; 165():109271. PubMed ID: 32771869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor blood vessel "normalization" improves the therapeutic efficacy of boron neutron capture therapy (BNCT) in experimental oral cancer.
    Molinari AJ; Pozzi EC; Monti Hughes A; Heber EM; Garabalino MA; Thorp SI; Miller M; Itoiz ME; Aromando RF; Nigg DW; Trivillin VA; Schwint AE
    Radiat Res; 2012 Jan; 177(1):59-68. PubMed ID: 21980958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanistic Modeling of the Relative Biological Effectiveness of Boron Neutron Capture Therapy.
    Streitmatter SW; Stewart RD; Moffitt G; Jevremovic T
    Cells; 2020 Oct; 9(10):. PubMed ID: 33076401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
    Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Boron neutron capture therapy: moving towards targeted therapy for locally recurrent head and neck squamous cell carcinoma.
    Sun Y
    Mil Med Res; 2019 Oct; 6(1):32. PubMed ID: 31651361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer.
    Kankaanranta L; Seppälä T; Koivunoro H; Saarilahti K; Atula T; Collan J; Salli E; Kortesniemi M; Uusi-Simola J; Mäkitie A; Seppänen M; Minn H; Kotiluoto P; Auterinen I; Savolainen S; Kouri M; Joensuu H
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):475-82. PubMed ID: 17689034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIF-1α affects sensitivity of murine squamous cell carcinoma to boron neutron capture therapy with BPA.
    Sanada Y; Takata T; Tanaka H; Sakurai Y; Watanabe T; Suzuki M; Masunaga SI
    Int J Radiat Biol; 2021; 97(10):1441-1449. PubMed ID: 34264166
    [No Abstract]   [Full Text] [Related]  

  • 28. Methods for radiation dose distribution analysis and treatment planning in boron neutron capture therapy.
    Nigg DW
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1121-34. PubMed ID: 8175397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Model for Estimating Dose-Rate Effects on Cell-Killing of Human Melanoma after Boron Neutron Capture Therapy.
    Matsuya Y; Fukunaga H; Omura M; Date H
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Designation Products: Boron Neutron Capture Therapy for Head and Neck Carcinoma.
    Kanno H; Nagata H; Ishiguro A; Tsuzuranuki S; Nakano S; Nonaka T; Kiyohara K; Kimura T; Sugawara A; Okazaki Y; Takae S; Nakabayashi T; Arai H; Suzuki H
    Oncologist; 2021 Jul; 26(7):e1250-e1255. PubMed ID: 33928712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microdosimetry study of THOR BNCT beam using tissue equivalent proportional counter.
    Hsu FY; Hsiao HW; Tung CJ; Liu HM; Chou FI
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S175-8. PubMed ID: 19447042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monte Carlo-based treatment planning for boron neutron capture therapy using custom designed models automatically generated from CT data.
    Zamenhof R; Redmond E; Solares G; Katz D; Riley K; Kiger S; Harling O
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):383-97. PubMed ID: 8635948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Boron neutron capture therapy for head and neck cancer: Relevance of nuclear-cytoplasmic volume ratio and anti-tumor effect. -A preliminary report.
    Aihara T; Hiratsuka J; Kamitani N; Nishimura H; Ono K
    Appl Radiat Isot; 2020 Sep; 163():109212. PubMed ID: 32561048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer.
    Barth RF; Vicente MG; Harling OK; Kiger WS; Riley KJ; Binns PJ; Wagner FM; Suzuki M; Aihara T; Kato I; Kawabata S
    Radiat Oncol; 2012 Aug; 7():146. PubMed ID: 22929110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors.
    Barth RF; Grecula JC; Yang W; Rotaru JH; Nawrocky M; Gupta N; Albertson BJ; Ferketich AK; Moeschberger ML; Coderre JA; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):267-77. PubMed ID: 14697448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of dose distributions in gross tumor volume between boron neutron capture therapy alone and combined boron neutron capture therapy plus intensity modulation radiation therapy for head and neck cancer.
    Lee JC; Chuang KS; Hsueh Liu YW; Lin TY; Teng YC; Wang LW
    PLoS One; 2019; 14(4):e0210626. PubMed ID: 30947267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment results of boron neutron capture therapy using intra-arterial administration of boron compounds for recurrent head and neck cancer.
    Fuwa N; Suzuki M; Sakurai Y; Nagata K; Kinashi Y; Masunaga S; Maruhashi A; Imahori Y; Kodaira T; Tachibana H; Nakamura T; Ono K
    Br J Radiol; 2008 Sep; 81(969):749-52. PubMed ID: 18541628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profile analysis of adverse events after boron neutron capture therapy for head and neck cancer: a sub-analysis of the JHN002 study.
    Hirose K; Sato M; Kato T; Takayama K; Suzuki M; Yamaguchi H; Seto I; Kikuchi Y; Murakami M; Takai Y
    J Radiat Res; 2022 May; 63(3):393-401. PubMed ID: 35388879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Boron neutron capture therapy (BNCT) for malignant melanoma with special reference to absorbed doses to the normal skin and tumor.
    Fukuda H; Hiratsuka J; Kobayashi T; Sakurai Y; Yoshino K; Karashima H; Turu K; Araki K; Mishima Y; Ichihashi M
    Australas Phys Eng Sci Med; 2003 Sep; 26(3):97-103. PubMed ID: 14626847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of intra-arterial administration of boron compounds on dose-volume histograms in boron neutron capture therapy for recurrent head-and-neck tumors.
    Suzuki M; Sakurai Y; Nagata K; Kinashi Y; Masunaga S; Ono K; Maruhashi A; Kato I; Fuwa N; Hiratsuka J; Imahori Y
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1523-7. PubMed ID: 17056200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.